IDH2 and oligodendroglioma: For DIRAS-2 we detected significantly increased promoter methylation compared to non-neoplastic brain tissues in IDH-mutant astrocytic gliomas, but not in IDH-wild-type astrocytic gliomas and in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.